{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T07:47:11Z","timestamp":1751960831981,"version":"3.38.0"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T00:00:00Z","timestamp":1740614400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.cca.2025.120209","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T16:10:07Z","timestamp":1740154207000},"page":"120209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Osteopontin in rheumatic diseases: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"570","author":[{"given":"Stefano","family":"Zoroddu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biagio Di","family":"Lorenzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Paliogiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arduino A.","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciriaco","family":"Carru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Zinellu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2025.120209_b0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.17925\/RMD.2024.3.1.4","article-title":"Navigating comorbidities in chronic inflammatory rheumatic diseases: insight and strategies","volume":"3","author":"Hmamouchi","year":"2024","journal-title":"Touch Reviews in RMD"},{"key":"10.1016\/j.cca.2025.120209_b0010","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s13023-021-01945-8","article-title":"The combined prevalence of classified rare rheumatic diseases is almost double that of ankylosing spondylitis","volume":"16","author":"Leyens","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.cca.2025.120209_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.joclim.2024.100338","article-title":"Impact of climate change on rheumatic diseases: a scoping review","volume":"19","author":"Katsumoto","year":"2024","journal-title":"The Journal of Climate Change and Health"},{"key":"10.1016\/j.cca.2025.120209_b0020","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2665-9913(23)00211-4","article-title":"Global, regional, and national burden of rheumatoid arthritis, 1990\u20132020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021","volume":"5","author":"Black","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0025","doi-asserted-by":"crossref","DOI":"10.1515\/ohe-2023-0040","article-title":"Advancing rheumatic disease treatment: a journey towards better lives","volume":"5","author":"Rehman","year":"2024","journal-title":"Open Health"},{"key":"10.1016\/j.cca.2025.120209_b0030","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.3390\/cells10113017","article-title":"Recent advances in understanding the pathogenesis of rheumatoid arthritis: new treatment strategies","volume":"10","author":"Mueller","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.cca.2025.120209_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1014853","article-title":"Osteopontin - The stirring multifunctional regulatory factor in multisystem aging","volume":"13","author":"Du","year":"2022","journal-title":"Front Endocrinol (lausanne)"},{"key":"10.1016\/j.cca.2025.120209_b0040","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/nu16020312","article-title":"Immunoregulatory roles of osteopontin in diseases","volume":"16","author":"Wang","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2025.120209_b0045","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s12079-009-0068-0","article-title":"The role of osteopontin in inflammatory processes","volume":"3","author":"Lund","year":"2009","journal-title":"J Cell Commun Signal"},{"key":"10.1016\/j.cca.2025.120209_b0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2015.00201","article-title":"Interactions between hyaluronan and its receptors (CD44, RHAMM) regulate the activities of inflammation and cancer","volume":"6","author":"Misra","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2025.120209_b0055","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/imr.13081","article-title":"Osteopontin\/secreted phosphoprotein\u20101 harnesses glial\u2010, immune\u2010, and neuronal cell ligand\u2010receptor interactions to sense and regulate acute and chronic neuroinflammation","volume":"311","author":"Yim","year":"2022","journal-title":"Immunol Rev"},{"key":"10.1016\/j.cca.2025.120209_b0060","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/biom13030502","article-title":"Osteopontin: a bone-derived protein involved in rheumatoid arthritis and osteoarthritis immunopathology","volume":"13","author":"Mart\u00edn-M\u00e1rquez","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2025.120209_b0065","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1038\/jid.2012.32","article-title":"Osteopontin in systemic sclerosis and its role in dermal fibrosis","volume":"132","author":"Wu","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.cca.2025.120209_b0070","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/keh558","article-title":"Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus","volume":"44","author":"Wong","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.cca.2025.120209_b0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/s13054-015-0988-4","article-title":"Persistently elevated osteopontin serum levels predict mortality in critically ill patients","volume":"19","author":"Roderburg","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2025.120209_b0080","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10067-013-2375-3","article-title":"Serum level of osteopontin as an inflammatory marker does not indicate disease activity or responsiveness to therapeutic treatments in patients with rheumatoid arthritis","volume":"33","author":"Ji","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.28272","article-title":"Plasma levels of osteopontin from birth to adulthood","volume":"67","author":"Nourkami-Tutdibi","year":"2020","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.cca.2025.120209_b0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/nu16020312","article-title":"Immunoregulatory roles of osteopontin in diseases","volume":"16","author":"Wang","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.cca.2025.120209_b0095","doi-asserted-by":"crossref","first-page":"13080","DOI":"10.3390\/ijms252313080","article-title":"The association of anti-sm with osteopontin related to cognitive impairment in a pristane-induced lupus BALB\/c mice model","volume":"25","author":"Gonz\u00e1lez-Inostroz","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2025.120209_b0100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00296-014-3122-z","article-title":"Role of osteopontin in rheumatoid arthritis","volume":"35","author":"Zhang","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.cca.2025.120209_b0105","first-page":"1","article-title":"Plasma concentration of osteopontin (OPN) in children with systemic lupus erythematosus: relationship with disease activity","volume":"7","author":"Afify","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/j.cca.2025.120209_b0110","unstructured":"Statistical Power Analysis for the Behavioral Sciences - Jacob Cohen - Google Libri n.d. https:\/\/books.google.it\/books?hl=it&lr=&id=rEe0BQAAQBAJ&oi=fnd&pg=PP1&ots=sxTZQwRWt6&sig=Kt4dZ1N36LK-_BUatMXVLy4VpiI&redir_esc=y#v=onepage&q&f=false (accessed March 8, 2024)."},{"key":"10.1016\/j.cca.2025.120209_b0115","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cca.2025.120209_b0120","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cca.2025.120209_b0125","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.cca.2025.120209_b0130","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-11-41","article-title":"Quantifying, displaying and accounting for heterogeneity in the meta-analysis of RCTs using standard and generalised Q statistics","volume":"11","author":"Bowden","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.cca.2025.120209_b0135","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/j.cca.2025.120209_b0140","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cca.2025.120209_b0145","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/j.cca.2025.120209_b0150","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.cca.2025.120209_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-024-07291-7","article-title":"Osteopontin, osteoprotegerin and musculoskeletal ultrasound findings in first-degree relatives of rheumatoid arthritis: potential markers of preclinical disease","volume":"25","author":"Soliman","year":"2024","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.cca.2025.120209_b0160","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11739-023-03192-0","article-title":"Vascular health in subjects with rheumatoid arthritis: assessment of endothelial function indices and serum biomarkers of vascular damage","volume":"18","author":"Daidone","year":"2023","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.cca.2025.120209_b0165","article-title":"Osteopontin as an early predictor of atherosclerosis in attack-free Familial Mediterranean fever patients","volume":"102","author":"Baspinar","year":"2023","journal-title":"Medicine (united States)"},{"key":"10.1016\/j.cca.2025.120209_b0170","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1007\/s12325-022-02171-9","article-title":"A decreased absolute number of treg cells in patients with active rheumatoid arthritis is associated with elevated serum osteopontin levels with disease progression","volume":"39","author":"Xie","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/j.cca.2025.120209_b0175","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.41955","article-title":"Association of increased serum lipopolysaccharide, but not microbial dysbiosis, with obesity-related osteoarthritis","volume":"74","author":"Loeser","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0180","first-page":"121","article-title":"Serum biomarkers of bone and immune function for diagnosis of rheumatoid arthritis","volume":"65","author":"AL-Rawi","year":"2022","journal-title":"Egypt J Chem"},{"key":"10.1016\/j.cca.2025.120209_b0185","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10067-020-05150-z","article-title":"Serum levels of leptin, osteopontin, and sclerostin in patients with and without knee osteoarthritis","volume":"40","author":"Min","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0190","doi-asserted-by":"crossref","first-page":"240","DOI":"10.9734\/jpri\/2021\/v33i39A32166","article-title":"Determination of clinical utility of novel biochemical markers in osteoarthritis","author":"Kondhalkar","year":"2021","journal-title":"J Pharm Res Int"},{"key":"10.1016\/j.cca.2025.120209_b0195","doi-asserted-by":"crossref","first-page":"271","DOI":"10.14232\/abs.2021.2.271-283","article-title":"Inflammatory and bone biomarkers\/composites as a predictive tool for clinical characteristics of rheumatoid arthritis patients","volume":"2","author":"Ali","year":"2022","journal-title":"Acta Biologica Szegediensis"},{"key":"10.1016\/j.cca.2025.120209_b0200","unstructured":"Feng L, Lou B, Wang Y, Sun H, Song J, Liu Y. The relationship between the serum and synovial fluid osteopontin (OPN), cartilage oligomeric matrix protein (COMP), and the severity of knee osteoarthritis (KOA) assessed by radiology 2020."},{"key":"10.1016\/j.cca.2025.120209_b0205","doi-asserted-by":"crossref","first-page":"492","DOI":"10.3899\/jrheum.180713","article-title":"Osteopontin and disease activity in patients with recent-onset systemic lupus erythematosus: results from the SLICC inception cohort","volume":"46","author":"Wirestam","year":"2019","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0210","unstructured":"The role of osteopontin as a candidate biomarker of renal involvement in systemic lupus erythematosus - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/31074728\/ (accessed November 29, 2024)."},{"key":"10.1016\/j.cca.2025.120209_b0215","article-title":"Polymorphisms in the osteopontin are associated with susceptibility to ankylosing spondylitis in a han chinese population","volume":"2018","author":"Li","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cca.2025.120209_b0220","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2318386","article-title":"Circulating semaphorin 4D as a marker for predicting radiographic progression in patients with rheumatoid arthritis","volume":"2018","author":"Ha","year":"2018","journal-title":"Dis Markers"},{"key":"10.1016\/j.cca.2025.120209_b0225","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000225","article-title":"Osteopontin is associated with disease severity and antiphospholipid syndrome in well characterised Swedish cases of SLE","volume":"4","author":"Wirestam","year":"2017","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.cca.2025.120209_b0230","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.17219\/acem\/68627","article-title":"Serum osteopontin and vitronectin levels in systemic sclerosis","volume":"26","author":"Gundogdu","year":"2017","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.cca.2025.120209_b0235","unstructured":"Assessment of ankylosing spondylitis by serum cytokine profile n.d. https:\/\/www.researchgate.net\/publication\/310490725_Assessment_of_ankylosing_spondylitis_by_serum_cytokine_profile (accessed November 29, 2024)."},{"key":"10.1016\/j.cca.2025.120209_b0240","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.rbre.2016.04.002","article-title":"Methylene tetrahydrofolate reductase, transforming growth factor-\u03b21 and lymphotoxin-\u03b1 genes polymorphisms and susceptibility to rheumatoid arthritis","volume":"56","author":"Shaker","year":"2016","journal-title":"Revista Brasileira De Reumatologia (english Edition)"},{"key":"10.1016\/j.cca.2025.120209_b0245","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3892\/br.2016.589","article-title":"Association of the osteopontin rs1126616 polymorphism and a higher serum osteopontin level with lupus nephritis","volume":"4","author":"Salimi1","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.cca.2025.120209_b0250","unstructured":"Increased osteopontin in muscle and serum from patients with idiopathic inflammatory myopathies - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/25936410\/ (accessed November 29, 2024)."},{"key":"10.1016\/j.cca.2025.120209_b0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejr.2014.05.001","article-title":"Plasma and synovial osteopontin levels, are they associated with disease severity of primary knee osteoarthritis in Egyptian patients?","volume":"37","author":"Haider","year":"2015","journal-title":"The Egyptian Rheumatologist"},{"key":"10.1016\/j.cca.2025.120209_b0260","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s10067-014-2665-4","article-title":"Osteopontin circulating levels correlate with renal involvement in systemic lupus erythematosus and are lower in ACE inhibitor-treated patients","volume":"33","author":"Quaglia","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0265","unstructured":"Correlation between two biomarkers of atherosclerosis, osteopontin and angiopoietin-2, in non-diabetic ankylosing spondylitis patients undergoing TNF-\u03b1 antagonist therapy - PubMed n.d. https:\/\/pubmed.ncbi.nlm.nih.gov\/24295386\/ (accessed November 29, 2024)."},{"key":"10.1016\/j.cca.2025.120209_b0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S1995-7645(13)60042-5","article-title":"Expression of NF-\u03baB and osteopontin of synovial fluid of patients with knee osteoarthritis","volume":"6","author":"Qin","year":"2013","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.cca.2025.120209_b0275","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s10875-012-9820-y","article-title":"Soluble levels of osteopontin in patients with Behcet\u2019s disease: association with disease activity and vascular involvement","volume":"33","author":"Bassyouni","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.cca.2025.120209_b0280","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejr.2012.04.003","article-title":"Plasma and synovial fluid osteopontin levels in patients with knee osteoarthritis: Relation to radiological grade","volume":"34","author":"Mohammed","year":"2012","journal-title":"The Egyptian Rheumatologist"},{"key":"10.1016\/j.cca.2025.120209_b0285","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1684\/ejd.2011.1252","article-title":"Plasma osteopontin levels in patients with Behcet\u2019s disease and psoriasis","volume":"21","author":"Erturkler","year":"2011","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.cca.2025.120209_b0290","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.humimm.2011.03.016","article-title":"Beh\u00e7et\u2019s disease exhibits an increased osteopontin serum level in active stage but no association with osteopontin and its receptor gene polymorphisms","volume":"72","author":"Chu","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cca.2025.120209_b0295","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.humimm.2011.06.009","article-title":"Association of osteopontin regulatory polymorphisms with systemic sclerosis","volume":"72","author":"Barizzone","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cca.2025.120209_b0300","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3899\/jrheum.090582","article-title":"Thrombin-cleaved osteopontin is increased in urine of patients with rheumatoid arthritis","volume":"37","author":"Shio","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.cca.2025.120209_b0305","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/ard.2009.113621","article-title":"Osteopontin in antineutrophil cytoplasmic autoantibody-associated vasculitis: relation to disease activity, organ manifestation and immunosuppressive therapy","volume":"69","author":"Lorenzen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.cca.2025.120209_b0310","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1093\/rheumatology\/ken385","article-title":"Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cca.2025.120209_b0315","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2119\/molmed.2009.00052","article-title":"Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis","volume":"15","author":"Bazzichi","year":"2009","journal-title":"Mol. Med."},{"key":"10.1016\/j.cca.2025.120209_b0320","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.clinbiochem.2009.02.002","article-title":"Correlation of plasma and synovial fluid osteopontin with disease severity in knee osteoarthritis","volume":"42","author":"Honsawek","year":"2009","journal-title":"Clin Biochem"},{"key":"10.1016\/j.cca.2025.120209_b0325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejr.2016.03.002","article-title":"Methylene tetrahydrofolate reductase (MTHFR) gene polymorphisms in rheumatoid arthritis patients: correlation with serum osteopontin levels and disease activity","volume":"38","author":"Shaker","year":"2016","journal-title":"The Egyptian Rheumatologist"},{"key":"10.1016\/j.cca.2025.120209_b0330","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3390\/biom13030502","article-title":"Osteopontin: a bone-derived protein involved in rheumatoid arthritis and osteoarthritis immunopathology","volume":"13","author":"Mart\u00edn-M\u00e1rquez","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.cca.2025.120209_b0335","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1161\/ATVBAHA.107.144824","article-title":"Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease","volume":"27","author":"Scatena","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.cca.2025.120209_b0340","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1172\/JCI200523273","article-title":"Role of osteopontin in amplification and perpetuation of rheumatoid synovitis","volume":"115","author":"Xu","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2025.120209_b0345","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1063497","article-title":"Mesangial cell: a hub in lupus nephritis","volume":"13","author":"Liu","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.cca.2025.120209_b0350","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.3390\/biomedicines11051356","article-title":"Osteopontin as a biomarker in chronic kidney disease","volume":"11","author":"Sinha","year":"2023","journal-title":"Biomedicines."},{"key":"10.1016\/j.cca.2025.120209_b0355","first-page":"1","article-title":"Adiponectin aggravates bone erosion by promoting osteopontin production in synovial tissue of rheumatoid arthritis","volume":"20","author":"Qian","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.cca.2025.120209_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2024.101252","article-title":"Emerging diagnostic and therapeutic challenges for skin fibrosis in systemic sclerosis","volume":"96","author":"Abraham","year":"2024","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.cca.2025.120209_b0365","first-page":"S4","article-title":"chronic inflammation (inflammaging) and its potential contribution to age-associated diseases","volume":"69","author":"Franceschi","year":"2014","journal-title":"The Journals of Gerontology: Series A"},{"key":"10.1016\/j.cca.2025.120209_b0370","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.145811","article-title":"Osteopontin promotes age-related adipose tissue remodeling through senescence-associated macrophage dysfunction","volume":"8","author":"Sawaki","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.cca.2025.120209_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/lifemeta\/load028","article-title":"Metabolic reprogramming in inflammaging and aging in T cells","volume":"2","author":"Bevilacqua","year":"2023","journal-title":"Life Metabolism"},{"key":"10.1016\/j.cca.2025.120209_b0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13054-015-0988-4","article-title":"Persistently elevated osteopontin serum levels predict mortality in critically ill patients","volume":"19","author":"Roderburg","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/j.cca.2025.120209_b0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-26187-w","article-title":"Assessing the feasibility of neutralizing osteopontin with various therapeutic antibody modalities","volume":"8","author":"Farrokhi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2025.120209_b0390","doi-asserted-by":"crossref","DOI":"10.1111\/eci.14365","article-title":"Circulating Fetuin-A concentrations in rheumatic diseases: a systematic review and meta-analysis","author":"Di Lorenzo","year":"2024","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/j.cca.2025.120209_b0395","article-title":"Association between blood Pentraxin-3 concentrations and rheumatic diseases: a systematic review and meta-analysis","volume":"54","author":"Di Lorenzo","year":"2024","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.cca.2025.120209_b0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12891-021-04392-5","article-title":"Association between serum bone biomarker levels and therapeutic response to abatacept in patients with rheumatoid arthritis (RA): a multicenter, prospective, and observational RA ultrasound cohort study in Japan","volume":"22","author":"Kawashiri","year":"2021","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.cca.2025.120209_b0405","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.joca.2009.07.009","article-title":"Elevated osteopontin level of synovial fluid and articular cartilage is associated with disease severity in knee osteoarthritis patients","volume":"18","author":"Gao","year":"2010","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.cca.2025.120209_b0410","first-page":"1","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.cca.2025.120209_b0415","doi-asserted-by":"crossref","first-page":"82S","DOI":"10.1177\/1947603520942941","article-title":"Synovial fluid biomarkers in knee osteoarthritis: a systematic review and quantitative evaluation using BIPEDs criteria","volume":"13","author":"Boffa","year":"2021","journal-title":"Cartilage"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898125000889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T17:15:09Z","timestamp":1741367709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898125000889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":83,"alternative-id":["S0009898125000889"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2025.120209","relation":{},"ISSN":["0009-8981"],"issn-type":[{"type":"print","value":"0009-8981"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteopontin in rheumatic diseases: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2025.120209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"120209"}}